Skip to main content

Webinar Now Available On Demand - Advancing Immuno-oncology: Innovative solutions for adoptive cell therapy

Scaling Biotech Operations: How Ventus Cut Costs & Boosted Productivity

150K +

In Savings

Ventus Therapeutics Saved $150K+ and Scaled Research Without Adding Headcount

 

puzzle

The Challenge

As Ventus expanded operations across the U.S. and Canada, rapid growth introduced new complexity.

  • Administrative strain: Scientists lost valuable time to manual tasks without dedicated lab operations support.

  • Rising workload: A lean AP team faced growing pressure as order volume increased.

  • Limited visibility: Financial reporting and compliance became more difficult without centralized systems.

solution

The Solution

To scale efficiently, Ventus implemented the Prendio-BioProcure platform and services to maintain research velocity.

  • 3-way match functionality: A key factor in their decision, ensuring accuracy and control across purchasing and payments.

  • Seamless onboarding: More than 50 users adopted the platform smoothly, with workflows aligned to existing processes.

  • Integrated approach: Combined technology and services to support growth without adding operational burden.

graph

The Impact

Ventus achieved measurable results through a life science procurement transformation that reduced costs and boosted productivity.

  • $150K+ cost savings reinvested in advancing their science.

  • Hundreds of hours saved by automating and streamlining procurement workflows.

  • Stronger vendor relationships and accuracy through automated invoice processing and financial tracking.

quote

Prendio-BioProcure expanded our team without having to make a full-time hire. It is very flexible, and as we continue to grow and continue to hire, we’re able to use the same system. We have worked with the team to find various cost saving initiatives like sourcing from other vendors than the ones we typically use, setting up annual POs for repeat lab supplies, etc.

Yelena Shuster-Rosen Controller, Ventus Therapeutics

 

Ventus-Therapeutics-logo

Company Snapshot

Ventus Therapeutics is a Series C clinical-stage biotech with locations in the United States and Canada, developing novel small-molecule therapies for hard-to-target proteins in immunology, inflammation, andneurology.

Want to learn more about Prendio?

SCHEDULE A DEMO

© Prendio. All Rights Reserved 2017-2025. Privacy Policy